Market Cap (In CNY)
8.16 Billion
Revenue (In CNY)
2.17 Billion
Net Income (In CNY)
421.29 Million
Avg. Volume
1.9 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.28-16.99
- PE
- -
- EPS
- -
- Beta Value
- 0.449
- ISIN
- CNE100000DY9
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yuangang Xie
- Employee Count
- -
- Website
- https://www.sanjin.com.cn
- Ipo Date
- 2009-07-10
- Details
- Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. The company was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.
More Stocks
-
GOODN
-
FIZZ
-
QIAQiagen N.V.
QIA
-
0884
-
CCV
-
603588
-
WRAP
-
600770Jiangsu Zongyi Co.,LTD
600770